Press Release - SUTUREGARD® Medical Announces How To Document Use of their Devices in Modernizing Medicine’s EHR system, EMA® | Press Release
X

SUTUREGARD® Medical, Inc. Blog

 
14Jul

Press Release - SUTUREGARD® Medical Announces How To Document Use of their Devices in Modernizing Medicine’s EHR system, EMA®

SUTUREGARD® has recently announced how to document the use of HEMIGARD® ARS and SUTUREGARD® ISR devices for your complex repairs in EMA with Modernizing Medicine.

EMA has clickable boxes to simplify your documentation and coding when using the HEMIGARD® ARS and SUTUREGARD® ISR devices for your closures. The steps are easy and identifiable, below is an example for when using the HEMIGARD®.

Step 1: After documenting the excision, click “Complex Repair”

Step 1

Step 2: EMA will ask if a SUTUREGARD® ISR or HEMIGARD® ARS device was used. Select “HEMIGARD”.

Step 2

Step 3: Select the caliber of suture used for the retention suture. You can change the default using the “sticky” green ball in the box. Typically, the HEMIGARD® is used within 2-0 nylon.

Step 3

Step 4: Select the number of HEMIGARD® strips per side of the wound. One pouch of HEMIGARD® ARS devices contains two strips, one for each side of the wound. Here, we selected 1 strip per side.

Step 4

Final Step: Mark the “complex Requirement: Retention Suture Used” box as “Yes” to confirm that you placed the HEMIGARD® ARS device(s) and retention suture(s).

Based in Portland, Oregon, SUTUREGARD® Medical, Inc is a private company offering novel medical devices for surgeons to repair challenging surgical defects more simply. SUTUREGARD® medical devices are intended to provide minimal wound trauma and reduce the healing period after surgery, providing better results for patients.

Related

Elliptical wound tension and HEMIGARD™

Usually, excisional wounds are created with an ellipse: where the length of the wound is about 2-4 t...

Read More >

What is Basal Cell Carcinoma (BCC)?

A basal cell carcinoma (BCC) is one of the most common skin cancers. Every year, there are over 4 mi...

Read More >

Press Release - SUTUREGARD® Medical and Federated Healthcare Supply Sign Non-Exclusive Distribution Deal

SUTUREGARD® Medical has formed a non-exclusive distribution partnership with Federated Healthcare Su...

Read More >

Press Release - Patient Self-Removal of HEMIGARD During COVID Now Published

JAAD Case Reports recently published, “Use of a novel adhesive suture retention wound closure devic...

Read More >

Why We Use GluSeal® With Our HEMIGARD™- Assisted Skin Closures

Our research has demonstrated that the middle suture in an elliptical wound is under approximately s...

Read More >

Bill Lear, MD, Discusses Development of HEMIGARD ARS

Bill Lear, MD, Mohs surgeon now but 5-year emergency physician previously, talks with Dr. Mark Plast...

Read More >

Prevent and Manage Wound Dehiscence.

Making wound closure easier for surgeons and better for patients.

Contact Us